Inventor
MEHTALI MAJID
FR35 patents
⚠️ This page may combine multiple inventors who share the name “MEHTALI MAJID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRANSGENE SA
18 patentsUS6040174AMar 21, 2000
Defective adenoviruses and corresponding complementation lines
TRANSGENE SA212 citations97
US6204060B1Mar 20, 2001
Viral vectors and line for gene therapy
TRANSGENE SA66 citations94
US6133028AOct 17, 2000
Defective adenoviruses and corresponding complementation lines
TRANSGENE SA74 citations94
US6569677B1May 27, 2003
Modified adenoviral fiber and target adenoviruses
TRANSGENE SA34 citations92
US6475480B1Nov 5, 2002
Use of adenoviral E4 reading frames to improve expression of a gene of interest
TRANSGENE SA25 citations91
US6350575B1Feb 26, 2002
Helper viruses for the preparation of recombinant viral vectors
TRANSGENE SA25 citations91
US5889175AMar 30, 1999
Nucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replication
TRANSGENE SA20 citations89
US6399587B1Jun 4, 2002
Recombinant adenoviral vectors comprising a splicing sequence
TRANSGENE SA17 citations82
US6066478AMay 23, 2000
Helper viruses for preparing recombinant viral vectors
TRANSGENE SA6 citations72
US6479290B1Nov 12, 2002
Chimeric adenoviral vectors
TRANSGENE SA8 citations71
US6284252B1Sep 4, 2001
Transdominant TAT variants of the human immunodeficiency virus
TRANSGENE SA9 citations70
US6228369B1May 8, 2001
Composition of trans-dominant variants of viral proteins for obtaining an anti-viral effect
TRANSGENE SA9 citations69
US5981258ANov 9, 1999
Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect
TRANSGENE SA10 citations69
US6740511B1May 25, 2004
Modified adenoviral fibre and uses thereof
TRANSGENE SA10 citations68
US6960469B2Nov 1, 2005
Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
TRANSGENE SA2 citations62
US7067309B2Jun 27, 2006
Defective adenoviruses and corresponding complementation lines
TRANSGENE SA2 citations61
US7005277B2Feb 28, 2006
Defective adenoviruses and corresponding complementation lines
TRANSGENE SA2 citations61
US7482155B1Jan 27, 2009
Chimeric promoters for controlling expression in smooth muscle cells
TRANSGENE SA1 citations45
CRUCELL HOLLAND BV
6 patentsUS6974695B2Dec 13, 2005
Complementing cell lines
CRUCELL HOLLAND BV85 citations98
US6492169B1Dec 10, 2002
Complementing cell lines
CRUCELL HOLLAND BV113 citations98
US6869794B2Mar 22, 2005
Complementing cell lines
CRUCELL HOLLAND BV47 citations96
US7344883B2Mar 18, 2008
Complementing cell lines
CRUCELL HOLLAND BV11 citations92
US7250293B2Jul 31, 2007
Complementing cell lines
CRUCELL HOLLAND BV4 citations73
US9228205B2Jan 5, 2016
Complementing cell lines
CRUCELL HOLLAND BV1 citations63
MEHTALI MAJID
3 patentsUS8148132B2Apr 3, 2012
Production of viral vaccines in suspension on avian embryonic derived stem cell lines
MEHTALI MAJID11 citations79
US9040296B2May 26, 2015
Production of viral vaccines in suspension on avian embryonic derived stem cell lines
MEHTALI MAJID4 citations68
US9182408B2Nov 10, 2015
Method of screening by using conformation sensitive peptides
MEHTALI MAJID0 citations40
VALNEVA
3 patentsUS9260694B2Feb 16, 2016
Generation of duck cell lines
VALNEVA2 citations53
US9701945B2Jul 11, 2017
Production of viral vaccines in suspension on avian embryonic derived stem cell lines
VALNEVA0 citations47
US9822345B2Nov 21, 2017
Method of making a virus using duck embryonic derived stem cell lines
VALNEVA0 citations43